ModMed Buys Bonsai Health to Advance AI Patient Engagement
ModMed, a prominent provider of technology solutions for specialty medical practices, has announced the acquisition of Bonsai Health, an emerging leader in agentic AI-powered patient engagement. This strategic move represents a significant milestone in ModMed’s broader vision of building the “AI-Powered Practice,” a model that integrates advanced automation and intelligent workflows to enhance both clinical and administrative operations.
The addition of Bonsai Health introduces a new layer of proactive automation to ModMed’s ecosystem, particularly in the front office. Known for its innovative use of agentic AI, Bonsai’s platform specializes in automating patient reactivation and enabling seamless self-scheduling. These capabilities are designed to reduce the burden on administrative staff while simultaneously improving patient access to care. By incorporating Bonsai’s technology, ModMed aims to transform how medical practices manage patient engagement—shifting from reactive communication to proactive, data-driven interaction.
At the core of Bonsai Health’s platform is an advanced AI engine that operates behind the scenes to identify opportunities for engagement. It analyzes patient histories to detect gaps in care, such as missed follow-ups or overdue appointments, and cross-references this information with real-time provider availability. Once these opportunities are identified, the system automatically initiates outreach through multiple channels, including SMS and email. Patients can then schedule appointments directly through these communications, eliminating the need for manual intervention by staff.
This level of automation is particularly valuable in today’s healthcare environment, where administrative workloads are increasing and staffing shortages remain a persistent challenge. By automating routine tasks like appointment scheduling and patient outreach, practices can free up staff to focus on higher-value activities, such as patient care and complex case management. At the same time, patients benefit from a more convenient and responsive experience, which can lead to improved satisfaction and better health outcomes.
The integration of Bonsai Health’s capabilities also complements ModMed’s existing patient engagement tools, particularly those powered by Klara. While Klara serves as a centralized communication platform that enables staff to manage conversations and coordinate outreach, Bonsai adds a proactive dimension. Instead of waiting for staff to initiate contact, the AI system continuously monitors data and takes action autonomously. This combination creates a more comprehensive engagement strategy, blending human oversight with intelligent automation.
From a strategic perspective, the acquisition positions ModMed to accelerate innovation and expand its reach across a wide range of medical specialties. The company already supports nearly 50,000 providers in fields such as dermatology, ophthalmology, orthopedics, gastroenterology, and ENT. By integrating Bonsai’s technology into its platform, ModMed can deliver enhanced value to this extensive network, helping practices optimize their operations and improve patient engagement at scale.
Leadership from both organizations has emphasized the alignment of their missions and the potential impact of this partnership. ModMed’s executives have highlighted Bonsai Health’s focus on ensuring that patients receive the right care at the right time—a principle that closely aligns with ModMed’s vision for the future of healthcare technology. By combining their expertise and resources, the two companies aim to create a powerful innovation engine capable of driving meaningful change across the industry.
Bonsai Health’s leadership team, including its co-founders, brings significant experience in the patient engagement space. Their background includes building and scaling successful healthcare technology solutions, which adds depth to ModMed’s leadership and strengthens its ability to execute on its strategic goals. With access to ModMed’s extensive clinical datasets and infrastructure, Bonsai’s team will be able to further refine and expand their AI capabilities, accelerating the development of new features and applications.
The acquisition also reflects broader trends in healthcare, where artificial intelligence is increasingly being used to streamline operations and enhance patient care. Agentic AI, in particular, represents a shift toward systems that can act independently to achieve specific goals, rather than simply providing recommendations or insights. In the context of patient engagement, this means moving from tools that support staff workflows to systems that can autonomously manage and optimize those workflows.
This shift has significant implications for the future of healthcare delivery. As practices adopt more advanced AI technologies, they can become more efficient, responsive, and patient-centered. Automated systems can help ensure that no patient falls through the cracks, reducing missed appointments and improving continuity of care. At the same time, they can help practices maximize the use of their resources, filling schedule gaps and increasing overall productivity.
For investors and stakeholders, the acquisition underscores ModMed’s commitment to staying at the forefront of technological innovation. Backed by strong financial support, the company is well-positioned to continue investing in advanced solutions that address the evolving needs of healthcare providers. The addition of Bonsai Health not only enhances ModMed’s current offerings but also opens the door to new opportunities for growth and differentiation in a competitive market.
Looking ahead, the integration of Bonsai Health into ModMed’s platform is expected to unfold over time, with a focus on ensuring a seamless experience for existing users. Practices can anticipate new features and capabilities that leverage the combined strengths of both organizations, delivering greater efficiency and improved outcomes. As these technologies continue to evolve, they have the potential to redefine how healthcare practices operate, making them more agile, data-driven, and patient-focused.
In summary, ModMed’s acquisition of Bonsai Health marks a pivotal step in the evolution of AI-driven healthcare solutions. By bringing together complementary technologies and expertise, the company is advancing its vision of the AI-Powered Practice—one where intelligent automation enhances every aspect of patient engagement. This move not only strengthens ModMed’s position in the market but also highlights the growing importance of agentic AI in shaping the future of healthcare.
About ModMed
At ModMed, we empower medical practices to grow and scale by delivering better patient experiences with cloud, data and AI technologies. Through the AI-Powered PracticeTM, we help specialty medical providers simplify, automate and streamline clinical workflows and drive practice efficiency. Our specialty-specific EHR, practice management, revenue cycle management and analytics solutions, as well as products for patient engagement, payment processing and marketing, are trusted by nearly 50,000 providers to drive their clinical and operational success.
Clearlake Capital is a leading global alternative asset manager founded in 2006 with over $185 billion of assets under management. Clearlake offers a broad range of investment solutions across private equity, credit, infrastructure, secondaries, co-investments, and other related private market strategies. Through Pathway Capital Management1 a Clearlake company, the firm serves institutional and wealth investors seeking diversified access to private markets. Clearlake seeks to partner with experienced management teams by providing patient, long-term capital to businesses across multiple sectors. The firm aims to drive value through its active, hands-on operating approach, O.P.S.® (Operations, People, Strategy), which combines deep operational expertise with strategic and talent-focused initiatives. Headquartered in Santa Monica, Clearlake maintains 13 offices across the Americas, Europe, Asia, and the Middle East
